For press inquiries click here to contact us.
FierceBiotech
Immunomedics poaches AstraZeneca I-O executive as new research chief
Bloomberg Markets
Novartis CEO Spurs Rare-Disease Shift With $8.7 Billion Deal
Boston 25 News
All women over 30 should consider breakthrough test, scientist says
Reuters
High-flying biotech Loxo tempers bullish view for cancer drug
TechCrunch
Color rolls out a test to try to search for hereditary risk for heart conditions like arrhythmia
Endpoints
The biotech IPO party rocks on with $120M raise for I/O player Arcus Biosciences
FierceBiotech
Qiagen pays $40M to work with Natera on prenatal screening tests
Endpoints
MyoKardia steps closer to the launch of a groundbreaking heart trial after finding its low-dose starting point
Good Morning America
What to Know About the New Affordable BRCA Gene Test
Please see important disclaimers in the Terms section.
